Form D · Other Health Care
Urolith, LLC
Columbus, OH · CIK 0001292781
Offering snapshot reported Jan 15, 2020 · SEC filing
- Reported sold
- $23.4K Offering amount: $358K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $22K Reported outside-investor minimum
- First sale
- Jan 9, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 15, 2020 | Initial | $23,428 | No comparison | 1 | SEC filing |
| Jun 12, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-358140
Source: Form D, filed Jan 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Buergenthal | Director |
| Mark Dersch, Md | Director |
| Mark Dersch, M.D. | Director |
| Paresh Desai, Md | Director |
| Paresh G. Desai, M.D. | Director |
| Michael Desautel, Md | Director |
| Michael Desautel, M.D. | Director, Executive |
| Edward King, Md | Director, Executive |
| Edward King, M.D. | Director, Executive |
| Hughes Ric | Director |
| Manuel Seneriz, Md | Director |
| Manuel Seneriz, M.D. | Director |
| Andrew Sher, Md | Director |
| Andrew Sher, M.D. | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
100 W. 3rd Avenue, Suite 350
Columbus, OH, 43201
Columbus, OH, 43201